1H-MRS	proton magnetic resonance spectroscopy
3xTg	triple-transgenic
AD	Alzheimer’s disease
AMPAR	α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor
BBB	blood–brain barrier
CIS	chronic immobilization stress
CNS	central nervous system
CSF	cerebrospinal fluid
DEHP	bis(2-ethylhexyl) phthalate
EAAT	excitatory amino acid transporter
ECF	extracellular fluid
ECT	electroconvulsive therapy
GABA	γ-aminobutyric acid
Gln	glutamine
Glu	glutamate
Glx	Glu + Gln
GS	glutamine synthetase
iNOS	inducible nitric oxide synthase
KAR	kainate receptor
L-AAA	L-α-aminoadipic acid
MCI	mild cognitive impairment
MDD	major depressive disorder
MeAIB	α-methyl-amino-isobutyric acid
mGluR	metabotropic glutamate receptor
mPFC	medial prefrontal cortex
MSO	methionine sulfoximine
NMDAR	N-methyl-D-aspartate receptor
NMR	nuclear magnetic resonance
NOX	NADPH oxidase
PAG	phosphate-activated glutaminase
PFC	prefrontal cortex
PLC	prelimbic cortex
ROS/RNS	reactive oxygen/nitrogen species
sEPSC	spontaneous excitatory postsynaptic current
SNAT	sodium-coupled neutral amino acid transporter
VGLUT	vesicular glutamate transporter